Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Page 1
Developmental Trajectories of Anhedonia in Preclinical Models.
Birnie MT, Levis SC, Mahler SV, Baram TZ. Birnie MT, et al. Among authors: levis sc. Curr Top Behav Neurosci. 2022;58:23-41. doi: 10.1007/7854_2021_299. Curr Top Behav Neurosci. 2022. PMID: 35156184 Free PMC article.
It provides information about the development of anhedonia in the context of early-life adversity, and the power of preclinical models to tease out the diverse molecular, epigenetic, and network mechanisms that are responsible for anhedonia-like behaviors.Specifically, we first d …
It provides information about the development of anhedonia in the context of early-life adversity, and the power of preclinical models to te …
Near-future forest vulnerability to drought and fire varies across the western United States.
Buotte PC, Levis S, Law BE, Hudiburg TW, Rupp DE, Kent JJ. Buotte PC, et al. Among authors: levis s. Glob Chang Biol. 2019 Jan;25(1):290-303. doi: 10.1111/gcb.14490. Epub 2018 Nov 15. Glob Chang Biol. 2019. PMID: 30444042
We modified CLM to represent 13 major forest types in the western United States and ran simulations at a 4-km grid resolution, driven with climate projections from two general circulation models under one emissions scenario (RCP 8.5). We developed metrics of vulnerability to shor …
We modified CLM to represent 13 major forest types in the western United States and ran simulations at a 4-km grid resolution, driven with c …
Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
Levis S, Theodore G. Levis S, et al. J Manag Care Pharm. 2012 May;18(4 Suppl B):S1-15; discussion S13. doi: 10.18553/jmcp.2012.18.s4-b.1. J Manag Care Pharm. 2012. PMID: 22716221 Free PMC article.
The updated review examined 5 key questions focused on comparative review of all FDA-approved medicines for osteoporosis in fracture risk reduction, effectiveness in racial/ethnic subpopulations as well as different risk stratification using FRAX (World Health Organization Fractu …
The updated review examined 5 key questions focused on comparative review of all FDA-approved medicines for osteoporosis in fracture risk re …
Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.
Levis S, Strickman-Stein N, Doerge DR, Krischer J. Levis S, et al. Contemp Clin Trials. 2010 Jul;31(4):293-302. doi: 10.1016/j.cct.2010.03.007. Epub 2010 Mar 15. Contemp Clin Trials. 2010. PMID: 20230914 Free PMC article. Clinical Trial.
Following the results of the Women's Health Initiative, many women now decline estrogen replacement at the time of menopause and seek natural remedies that would treat menopausal symptoms and prevent bone loss and other long-term consequences of estrogen deficiency, but wi …
Following the results of the Women's Health Initiative, many women now decline estrogen replacement at the time of menopause and seek natura …
Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial.
Schwartz AV, Bauer DC, Cummings SR, Cauley JA, Ensrud KE, Palermo L, Wallace RB, Hochberg MC, Feldstein AC, Lombardi A, Black DM; FLEX Research Group. Schwartz AV, et al. J Bone Miner Res. 2010 May;25(5):976-82. doi: 10.1002/jbmr.11. J Bone Miner Res. 2010. PMID: 20200926 Free article. Clinical Trial.
In the Fracture Intervention Trial (FIT) Long Term Extension (FLEX) Trial, 10 years of alendronate (ALN) did not significantly reduce the risk of nonvertebral fractures (NVFs) compared with 5 years of ALN. ...In previous studies, ALN efficacy for NVF prevention in women wi …
In the Fracture Intervention Trial (FIT) Long Term Extension (FLEX) Trial, 10 years of alendronate (ALN) did not significantly reduce …
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR; FLEX Research Group. Black DM, et al. Among authors: levis s. JAMA. 2006 Dec 27;296(24):2927-38. doi: 10.1001/jama.296.24.2927. JAMA. 2006. PMID: 17190893 Clinical Trial.